MedElevator Войти в исследования
← Поиск публикаций

DOI 10.17998/jlc.2023.02.08

Медицинская библиотека · Journal of liver cancer · 2023

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study.

Yu Su Jong, Lee Yun Bin, Cho Eun Ju, Lee Jeong-Hoon, Kim Hyo-Cheol, Chung Jin Wook, Yoon Jung-Hwan, Kim Yoon Jun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND/AIM: To evaluate the applicability of transarterial chemoembolization (TACE) treatment with doxorubicin drug-eluting beads (DEBs) in advanced hepatocellular carcinoma (HCC) patients with portal vein invasion (PVI).

METHODS

This prospective study was approved by the institutional review board and informed consent was obtained from all participants. A total of 30 HCC patients with PVI received DEB-TACE between 2015 and 2018. The following parameters were evaluated: complications during DEB-TACE, abdominal pain, fever, and laboratory outcomes, including liver function change. Overall survival (OS), time to progression (TTP), and adverse events were also analyzed and assessed.

RESULTS

DEBs measuring 100-300 μm in diameter were loaded with doxorubicin (150 mg per procedure). There were no complications during DEB-TACE and no significant differences in the levels of prothrombin time, serum albumin, or total bilirubin at follow-up compared to baseline. The median TTP was 102 days (95% confidence interval [CI], 42-207 days) and the median OS was 216 days (95% CI, 160-336 days). Three patients (10%) had severe adverse reactions, including transient acute cholangitis (n=1), cerebellar infarction (n=1), and pulmonary embolism (n=1), but no treatment-related death occurred.

CONCLUSIONS

DEB-TACE may be a therapeutic option for advanced HCC patients with PVI.

Для цитирования: Yu Su Jong, Lee Yun Bin, Cho Eun Ju, Lee Jeong-Hoon, Kim Hyo-Cheol, Chung Jin Wook, Yoon Jung-Hwan, Kim Yoon Jun. Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study.. Journal of liver cancer. 2023. DOI: 10.17998/jlc.2023.02.08.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.